Insulet Corp. (PODD)
143.01
-2.41
(-1.66%)
USD |
NASDAQ |
Aug 25, 16:00
140.98
-2.03
(-1.42%)
After-Hours: 19:42
Insulet Cash from Operations (Quarterly) : 88.50M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 88.50M |
| March 31, 2026 | 113.80M |
| December 31, 2025 | 183.30M |
| September 30, 2025 | 125.70M |
| June 30, 2025 | 196.50M |
| March 31, 2025 | 63.80M |
| December 31, 2024 | 147.70M |
| September 30, 2024 | 98.50M |
| June 30, 2024 | 96.50M |
| March 31, 2024 | 87.60M |
| December 31, 2023 | 44.90M |
| September 30, 2023 | 56.00M |
| June 30, 2023 | 44.00M |
| March 31, 2023 | 0.50M |
| December 31, 2022 | 50.70M |
| September 30, 2022 | 56.70M |
| June 30, 2022 | 25.30M |
| March 31, 2022 | -13.70M |
| December 31, 2021 | -25.50M |
| September 30, 2021 | -25.80M |
| June 30, 2021 | 18.30M |
| March 31, 2021 | -35.10M |
| December 31, 2020 | -1.00M |
| September 30, 2020 | 62.20M |
| June 30, 2020 | 26.40M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.60M |
| December 31, 2019 | 46.93M |
| September 30, 2019 | 31.19M |
| June 30, 2019 | 13.91M |
| March 31, 2019 | 6.367M |
| December 31, 2018 | 30.44M |
| September 30, 2018 | 15.86M |
| June 30, 2018 | -6.129M |
| March 31, 2018 | -4.266M |
| December 31, 2017 | 21.80M |
| September 30, 2017 | 23.28M |
| June 30, 2017 | 17.96M |
| March 31, 2017 | -21.84M |
| December 31, 2016 | 20.07M |
| September 30, 2016 | 2.677M |
| June 30, 2016 | 3.681M |
| March 31, 2016 | -10.52M |
| December 31, 2015 | -18.60M |
| September 30, 2015 | 8.746M |
| June 30, 2015 | 0.785M |
| March 31, 2015 | -3.488M |
| December 31, 2014 | 4.607M |
| September 30, 2014 | 4.822M |
| June 30, 2014 | 0.508M |
| March 31, 2014 | -1.017M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.488B |
| DexCom, Inc. | 269.20M |
| Boston Scientific Corp. | 1.474B |
| PROCEPT BioRobotics Corp. | -19.25M |
| Globus Medical, Inc. | 209.74M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -37.40M |
| Cash from Financing (Quarterly) | 4.00M |
| Free Cash Flow | 265.70M |
| Free Cash Flow Per Share (Quarterly) | 0.7377 |
| Free Cash Flow to Equity (Quarterly) | 50.90M |
| Free Cash Flow to Firm (Quarterly) | 62.00M |
| Free Cash Flow Yield | 2.65% |